![Fabienne Steens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabienne Steens
Direttore degli Investimenti presso Biomedical Diagnostics NV
Posizioni attive di Fabienne Steens
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Direttore/Membro del Consiglio | 28/01/2003 | - |
Direttore degli Investimenti | 28/01/2003 | - |
Storia della carriera di Fabienne Steens
Statistiche
Distribuzione geografica
Belgio | 2 |
Posizioni
Director/Board Member | 1 |
Chief Investment Officer | 1 |
Settori
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Distribution Services |
- Borsa valori
- Insiders
- Fabienne Steens
- Esperienza